Possibia

3738358

Last Update Posted: 2019-01-30

Recruiting has ended

All Genders

accepted

19 Years-79 Years

39 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease

This clinical study will be conducted to evaluate the efficacy and safety of trehalose in patients with fatty liver disease. After 12-week intake, subjects will be checked up fat content in liver using CT scan.

Eligibility

Relevant conditions:

Non-alcoholic Fatty Liver

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov